Teleflex Incorporated (NYSE:TFX) Receives $257.29 Consensus PT from Brokerages

Teleflex Incorporated (NYSE:TFX) has received an average recommendation of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $257.29.

A number of research firms recently commented on TFX. JMP Securities reaffirmed a “market outperform” rating and set a $285.00 price target on shares of Teleflex in a research report on Friday, February 23rd. Royal Bank of Canada lowered their price target on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a research report on Friday, February 23rd. Truist Financial lowered their price target on shares of Teleflex from $240.00 to $219.00 and set a “hold” rating on the stock in a research report on Friday, May 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Friday, May 3rd. Finally, StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 23rd.

Teleflex Stock Performance

NYSE TFX opened at $207.09 on Friday. The firm has a 50-day moving average of $210.40 and a 200-day moving average of $228.30. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 2.51. The stock has a market cap of $9.75 billion, a PE ratio of 33.24, a P/E/G ratio of 2.06 and a beta of 1.16. Teleflex has a 52-week low of $177.63 and a 52-week high of $262.97.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.07 by $0.14. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The company had revenue of $737.80 million during the quarter, compared to analysts’ expectations of $726.85 million. During the same quarter last year, the company posted $3.09 EPS. Teleflex’s quarterly revenue was up 3.8% compared to the same quarter last year. On average, sell-side analysts anticipate that Teleflex will post 13.75 EPS for the current year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Wednesday, May 15th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.36 annualized dividend and a yield of 0.66%. Teleflex’s dividend payout ratio is presently 21.83%.

Institutional Investors Weigh In On Teleflex

Hedge funds have recently added to or reduced their stakes in the business. Kentucky Retirement Systems lifted its position in shares of Teleflex by 1.1% in the 4th quarter. Kentucky Retirement Systems now owns 3,760 shares of the medical technology company’s stock worth $938,000 after purchasing an additional 42 shares during the period. Venturi Wealth Management LLC lifted its position in shares of Teleflex by 33.3% in the 4th quarter. Venturi Wealth Management LLC now owns 184 shares of the medical technology company’s stock worth $46,000 after purchasing an additional 46 shares during the period. Huntington National Bank lifted its position in shares of Teleflex by 26.5% in the 3rd quarter. Huntington National Bank now owns 253 shares of the medical technology company’s stock worth $50,000 after purchasing an additional 53 shares during the period. KBC Group NV lifted its position in shares of Teleflex by 1.8% in the 4th quarter. KBC Group NV now owns 3,173 shares of the medical technology company’s stock worth $791,000 after purchasing an additional 55 shares during the period. Finally, Lindbrook Capital LLC lifted its position in shares of Teleflex by 75.3% in the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock worth $34,000 after purchasing an additional 58 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.